Extracellular matrix determinants of proteolytic and non-proteolytic cell migration

Trends in Cell Biology

Volumn 21, Issue 12, 2011, Pages 736-744

  Wolf, Katarina ^a   Friedl, Peter ^a,b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; MATRIX METALLOPROTEINASE; SERINE PROTEINASE;

ACIDIFICATION; ADAPTATION; CELL ADHESION; CELL DENSITY; CELL INVASION; CELL MIGRATION; CELL STRUCTURE; EXTRACELLULAR MATRIX; GEOMETRY; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL MOVEMENT; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; PROTEOLYSIS;

EID: 81355127254     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2011.09.006     Document Type: Review

References (95)

1. Kessenbrock K., et al. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141:52-67.
2. Egeblad M., et al. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 2010, 18:884-901.
3. Miller M.C., et al. Membrane type 1 matrix metalloproteinase is a crucial promoter of synovial invasion in human rheumatoid arthritis. Arthritis Rheum. 2009, 60:686-697.
4. Zucker S., Cao J. Selective matrix metalloproteinase (MMP) inhibitors in cancer therapy: ready for prime time?. Cancer Biol. Ther. 2009, 8:2371-2373.
5. Wolf K., et al. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J. Cell Biol. 2003, 160:267-277.
6. Sabeh F., et al. Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited. J. Cell Biol. 2009, 185:11-19.
7. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front. Biosci. 2006, 11:479-491.
8. Friedl P., Wolf K. Plasticity of cell migration: a multiscale tuning model. J. Cell Biol. 2010, 188:11-19.
9. Friedl P., Wolf K. Proteolytic interstitial cell migration: a five-step process. Cancer Metastasis Rev. 2009, 28:129-135.
10. Artym V.V., et al. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function. Cancer Res. 2006, 66:3034-3043.
11. Wolf K., et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat. Cell Biol. 2007, 9:893-904.
12. Packard B.Z., et al. Direct visualization of protease activity on cells migrating in three-dimensions. Matrix Biol. 2009, 28:3-10.
13. Friedl P., et al. Nuclear mechanics during cell migration. Curr. Opin. Cell Biol. 2011, 23:55-64.
14. Gerlitz G., Bustin M. The role of chromatin structure in cell migration. Trends Cell Biol. 2011, 21:6-11.
15. Lammermann T., et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 2008, 453:51-55.
16. Sahai E., et al. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility. J. Cell Biol. 2007, 176:35-42.
17. Lammermann T., Sixt M. Mechanical modes of 'amoeboid' cell migration. Curr. Opin. Cell Biol. 2009, 21:636-644.
18. Chaussepied M., et al. TGF-b2 induction regulates invasiveness of Theileria-transformed leukocytes and disease susceptibility. PLoS Pathog. 2010, 6:e1001197.
19. Butcher D.T., et al. A tense situation: forcing tumour progression. Nat. Rev. Cancer 2009, 9:108-122.
20. Discher D.E.P., et al. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
21. Elbjeirami W.M., et al. Enhancing mechanical properties of tissue-engineered constructs via lysyl oxidase crosslinking activity. J. Biomed. Mater. Res. A 2003, 66:513-521.
22. Enderling H., et al. Dependence of invadopodia function on collagen fiber spacing and cross-linking: computational modeling and experimental evidence. Biophys. J. 2008, 95:2203-2218.
23. Ehrbar M., et al. Elucidating the role of matrix stiffness in 3D cell migration and remodeling. Biophys. J. 2011, 100:284-293.
24. Wolf K., et al. Collagen-based cell migration models in vitro and in vivo. Semin. Cell Dev. Biol. 2009, 20:931-941.
25. Provenzano P.P., et al. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. Biophys. J. 2008, 95:5374-5384.
26. Levental K.R., et al. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009, 139:891-906.
27. Saltel F., et al. Apatite-mediated actin dynamics in resorbing osteoclasts. Mol. Biol. Cell 2004, 15:5231-5241.
28. Stoitzner P., et al. A close-up view of migrating Langerhans cells in the skin. J. Invest. Dermatol. 2002, 118:117-125.
29. Egeblad M., et al. Dynamic interplay between the collagen scaffold and tumor evolution. Curr. Opin. Cell Biol. 2010, 22:697-706.
30. Montes G.S. Structural biology of the fibres of the collagenous and elastic systems. Cell Biol. Int. 1996, 20:15-27.
31. Cuttle L., et al. Collagen in the scarless fetal skin wound: detection with picrosirius-polarization. Wound Repair Regen. 2005, 13:198-204.
32. Voisin M.B., et al. Venular basement membranes ubiquitously express matrix protein low-expression regions: characterization in multiple tissues and remodeling during inflammation. Am. J. Pathol. 2010, 176:482-495.
33. Alexander S., et al. Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. Histochem. Cell Biol. 2008, 130:1147-1154.
34. Karamichos D., et al. Collagen stiffness regulates cellular contraction and matrix remodeling gene expression. J. Biomed. Mater. Res. A 2007, 83:887-894.
35. Wagenaar-Miller R.A., et al. Complementary roles of intracellular and pericellular collagen degradation pathways in vivo. Mol. Cell. Biol. 2007, 27:6309-6322.
36. Mohamed M.M, Sloane B.F. Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 2006, 6:764-775.
37. Partridge J.J., et al. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-(1080) fibrosarcoma exhibiting high and low levels of intravasation and metastasis. J. Biol. Chem. 2007, 282:35964-35977.
38. Wilson S.R., et al. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J. Biol. Chem. 2009, 284:2584-2592.
39. Cavallo-Medved D., et al. Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation. Exp. Cell Res. 2009, 315:1234-1246.
40. Sakharov D.V., Rijken D.C. Superficial accumulation of plasminogen during plasma clot lysis. Circulation 1995, 92:1883-1890.
41. Bhole A.P., et al. Mechanical strain enhances survivability of collagen micronetworks in the presence of collagenase: implications for load-bearing matrix growth and stability. Philos. Transact. Ser. A: Math. Phys. Eng. Sci. 2009, 367:3339-3362.
42. Walvick R.P., et al. Visualization of clot lysis in a rat embolic stroke model: application to comparative lytic efficacy. Stroke. J. Cereb. Circ. 2011, 42:1110-1115.
43. Nesbitt S.A., Horton M.A. Trafficking of matrix collagens through bone-resorbing osteoclasts. Science 1997, 276:26626-26629.
44. Sabeh F., et al. Secreted versus membrane-anchored collagenases: relative roles in fibroblast-dependent collagenolysis and invasion. J. Biol. Chem. 2009, 284:23001-23011.
45. Wahlgren J., et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone-destructive lesions. J. Pathol. 2001, 194:217-224.
46. O'Brien P., O'Connor B.F. Seprase: an overview of an important matrix serine protease. Biochim. Biophys. Acta 2008, 1784:1130-1145.
47. Hotary K., et al. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 2000, 149:1309-1323.
48. Tam E.M., et al. Collagen binding properties of the membrane type-1 matrix metalloproteinase (MT1-MMP) hemopexin C domain. The ectodomain of the 44-kDa autocatalytic product of MT1-MMP inhibits cell invasion by disrupting native type I collagen cleavage. J. Biol. Chem. 2002, 277:39005-39014.
49. Fisher K.E., et al. MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices. J. Cell Sci. 2009, 122:4558-4569.
50. Holmbeck K., et al. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999, 99:81-92.
51. Stratman A.N., et al. Endothelial cell lumen and vascular guidance tunnel formation requires MT1-MMP-dependent proteolysis in 3-dimensional collagen matrices. Blood 2009, 114:237-247.
52. Sabeh F., et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J. Cell Biol. 2004, 167:769-781.
53. Quintanilla-Dieck M.J., et al. Expression and regulation of cathepsin K in skin fibroblasts. Exp. Dermatol. 2009, 18:596-602.
54. Lucattelli M., et al. Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema. Eur. Respir. J. 2003, 22:728-734.
55. Curino A.C., et al. Intracellular collagen degradation mediated by uPARAP/Endo180 is a major pathway of extracellular matrix turnover during malignancy. J. Cell Biol. 2005, 169:977-985.
56. Madsen D.H., et al. Extracellular collagenases and the endocytic receptor, urokinase plasminogen activator receptor-associated protein/Endo180, cooperate in fibroblast-mediated collagen degradation. J. Biol. Chem. 2007, 282:27037-27045.
57. Messaritou G., et al. Membrane type-1 matrix metalloproteinase activity is regulated by the endocytic collagen receptor Endo180. J. Cell Sci. 2009, 122:4042-4048.
58. Wolf K., et al. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2003, 102:3262-3269.
59. Friedl P., Wolf K. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp. 2003, 2003:277-285.
60. Ilina O., et al. Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and -independent collective cancer cell invasion. Phys. Biol. 2011, 8:015010.
61. Beadle C., et al. The role of myosin II in glioma invasion of the brain. Mol. Biol. Cell 2008, 19:3357-3368.
62. Wyckoff J.B., et al. ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo. Curr. Biol. 2006, 16:1515-1523.
63. Provenzano P.P., et al. Collagen density promotes mammary tumor initiation and progression. BMC Med. 2008, 6:11.
64. Provenzano P.P., et al. Shining new light on 3D cell motility and the metastatic process. Trends Cell Biol. 2009, 19:638-648.
65. Xue C., et al. Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res. 2006, 66:192-197.
66. Kozloff K.M., et al. Noninvasive optical detection of bone mineral. J. Bone Mineral Res. 2007, 22:1208-1216.
67. Martin C.K., et al. Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Res. 2010, 70:8607-8616.
68. Pflicke H., Sixt M. Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. J. Exp. Med. 2009, 206:2925-2935.
69. Voisin M.B., et al. Monocytes and neutrophils exhibit both distinct and common mechanisms in penetrating the vascular basement membrane in vivo. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1193-1199.
70. Wang S., et al. Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J. Exp. Med. 2006, 203:1519-1532.
71. Marom B., et al. Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9. J. Leuk. Biol. 2007, 81:1466-1476.
72. Huber A.R., Weiss S.J. Disruption of the subendothelial basement membrane during neutrophil diapedesis in an in vitro construct of a blood vessel wall. J. Clin. Invest. 1989, 83:1122-1136.
73. Hotary K., et al. A cancer cell metalloprotease triad regulates the basement membrane transmigration program. Genes Dev. 2006, 20:2673-2686.
74. Doyle A.D., et al. One-dimensional topography underlies three-dimensional fibrillar cell migration. J. Cell Biol. 2009, 184:481-490.
75. Rolli C.G., et al. Impact of tumor cell cytoskeleton organization on invasiveness and migration: a microchannel-based approach. PLoS ONE 2010, 5:e8726.
76. Friedl P., et al. Biological second and third harmonic generation microscopy. Curr. Protoc. Cell Biol. 2007, 34. 4.15.1-4.15.21.
77. Farrar M.J., et al. In vivo imaging of myelin in the vertebrate central nervous system using third harmonic generation microscopy. Biophys. J. 2011, 100:1362-1371.
78. Debarre D., et al. Imaging lipid bodies in cells and tissues using third-harmonic generation microscopy. Nat. Methods 2006, 3:47-53.
79. Ouyang M., et al. Simultaneous visualization of protumorigenic Src and MT1-MMP activities with fluorescence resonance energy transfer. Cancer Res. 2010, 70:2204-2212.
80. Blum G., et al. Comparative assessment of substrates and activity based probes as tools for non-invasive optical imaging of cysteine protease activity. PLoS ONE 2009, 4:e6374.
81. Jaffer F.A., et al. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury. J. Am. Coll. Cardiol. 2011, 57:2516-2526.
82. Koblinski J.E., et al. Unraveling the role of proteases in cancer. Clin. Chim. Acta 2000, 291:113-135.
83. Baramova E.N., et al. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett. 1997, 405:157-162.
84. Siconolfi L.B., Seeds N.W. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush. J. Neurosci. Res. 2003, 74:430-434.
85. Madsen D.H., et al. The non-phagocytic route of collagen uptake: a distinct degradation pathway. J. Biol. Chem. 2011, 286:26996-27010.
86. Wolf K., Friedl P. Mapping proteolytic cancer cell-extracellular matrix interfaces. Clin. Exp. Metastasis 2009, 26:289-298.
87. Linder S. The matrix corroded: podosomes and invadopodia in extracellular matrix degradation. Trends Cell Biol. 2007, 17:107-117.
88. Schoumacher M., et al. Actin, microtubules, and vimentin intermediate filaments cooperate for elongation of invadopodia. J. Cell Biol. 2010, 189:541-556.
89. Albini A., Noonan D.M. The 'chemoinvasion' assay, 25 years and still going strong: the use of reconstituted basement membranes to study cell invasion and angiogenesis. Curr. Opin. Cell Biol. 2010, 22:677-689.
90. Sidani M., et al. Probing the microenvironment of mammary tumors using multiphoton microscopy. J. Mammary Gland Biol. Neoplasia 2006, 11:151-163.
91. Raub C.B., et al. Noninvasive assessment of collagen gel microstructure and mechanics using multiphoton microscopy. Biophys. J. 2007, 92:2212-2222.
92. Lautenschlager F., et al. The regulatory role of cell mechanics for migration of differentiating myeloid cells. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:15696-15701.
93. Jiang X., et al. Two-photon fluorescence and second-harmonic generation imaging of collagen in human tissue based on multiphoton microscopy. Scanning 2011, 33:53-56.
94. Zengel P., et al. mu-Slide Chemotaxis: a new chamber for long-term chemotaxis studies. BMC Cell Biol. 2011, 12:21.
95. Schneider P., et al. Simultaneous 3D visualization and quantification of murine bone and bone vasculature using micro-computed tomography and vascular replica. Microsc. Res. Tech. 2009, 72:690-701.